Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
TripAdvisor
TRIP
$1.63B
| $4.11M | ﹤0.01% |
76,368
-29,847
| -28% | -$1.28M |
|
1677
PTC Therapeutics
PTCT
$5.78B
| $4.1M | ﹤0.01% |
86,581
-23,497
| -21% | -$1.4M |
|
|
ELME
1678
Elme Communities
ELME
$146M
| $4.1M | ﹤0.01% |
185,328
+71,533
| +63% | +$1.63M |
|
1679
First Financial Bancorp
FFBC
$3.61B
| $4.09M | ﹤0.01% |
170,637
+54,426
| +47% | +$1.2M |
|
1680
MGIC Investment
MTG
$6.27B
| $4.09M | ﹤0.01% |
295,220
+21,817
| +8% | +$278K |
|
1681
Frontdoor
FTDR
$5.36B
| $4.07M | ﹤0.01% |
75,712
+13,076
| +21% | +$713K |
|
1682
Stepan Co
SCL
$1.46B
| $4.07M | ﹤0.01% |
31,980
+488
| +2% | +$60.5K |
|
|
AEL
1683
DELISTED
American Equity Investment Life Holding Company
AEL
| $4.06M | ﹤0.01% |
128,929
+27,368
| +27% | +$815K |
|
1684
PUT
Murphy Oil
MUR
$5.17B
| $4.06M | ﹤0.01% |
+247,400
| New | +$3.87M |
|
|
TPTX
1685
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $4.06M | ﹤0.01% |
42,888
+29,163
| +212% | +$3.47M |
|
|
DCPH
1686
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.05M | ﹤0.01% |
90,367
+37,057
| +70% | +$1.73M |
|
1687
Quaker Houghton
KWR
$2.94B
| $4.04M | ﹤0.01% |
16,580
+1,547
| +10% | +$413K |
|
1688
SLM Corp
SLM
$5.16B
| $4.04M | ﹤0.01% |
224,524
+57,423
| +34% | +$871K |
|
1689
Live Oak Bancshares
LOB
$2.03B
| $4.03M | ﹤0.01% |
58,913
+49,766
| +544% | +$2.61M |
|
|
SFIX
1690
PUT
Stitch Fix
SFIX
$550M
| $4.03M | ﹤0.01% |
81,300
+60,500
| +291% | +$4.26M |
|
1691
Genpact
G
$6.07B
| $4.02M | ﹤0.01% |
93,937
+57,079
| +155% | +$2.37M |
|
|
XENT
1692
DELISTED
Intersect ENT, Inc
XENT
| $4.02M | ﹤0.01% |
192,705
+93,037
| +93% | +$2.15M |
|
1693
CVR Energy
CVI
$3.14B
| $4.02M | ﹤0.01% |
209,420
+131,138
| +168% | +$2.67M |
|
1694
Sarepta Therapeutics
SRPT
$1.68B
| $4.01M | ﹤0.01% |
53,886
+223
| +0.4% | +$20.6K |
|
1695
Sunstone Hotel Investors
SHO
$2.18B
| $4.01M | ﹤0.01% |
321,825
+206,675
| +179% | +$2.47M |
|
1696
First Trust Value Line Dividend Fund
FVD
$8.37B
| $4.01M | ﹤0.01% |
+105,483
| New | +$3.81M |
|
1697
Range Resources
RRC
$8.91B
| $4M | ﹤0.01% |
387,051
-49,521
| -11% | -$481K |
|
1698
Credit Acceptance
CACC
$6.15B
| $3.99M | ﹤0.01% |
11,088
-14,692
| -57% | -$5.33M |
|
1699
Boston Beer
SAM
$1.9B
| $3.99M | ﹤0.01% |
3,311
-981
| -23% | -$1.03M |
|
1700
Medpace
MEDP
$16.4B
| $3.99M | ﹤0.01% |
24,329
-16,679
| -41% | -$2.55M |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.